• HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • Articles
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorials
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your Course or Conference
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR Funded?
    • Editorial Board
    • Peer Reviewers
    • ACNR Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Journal Signup
    • ACNR Privacy Policy
This website is intended for healthcare professionals
ACNR
  • HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • Articles
      • Articles
      • History
      • Letters to the Editor
      • Reviews
      • Personal Perspectives
      • View All
    • Book Reviews
    • Case Reports
    • News
    • Project Neurology Webinar Series
    • Sponsored Editorials
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your Course or Conference
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR Funded?
    • Editorial Board
    • Peer Reviewers
    • ACNR Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • ACNR Online Community Signup
    • ACNR Privacy Policy
  • Menu

ACNR ARTICLES

Computed Tomography in Neurology

Publication Date: 17 Dec 2008

Article written by:
Dr Justin Cross

Author

  • Dr Justin Cross

Dr Justin Cross trained in neuroradiology at Addenbrooke’s Hospital, Cambridge UK and at the University of Toronto, Canada. He has a special interest in paeditric neuroradiology and has published articles on the measurement of cerebral tumour volume, carotid imaging and the use of spectroscopy in clinical practice.

Correspondence Address:
Dr Justin Cross, Department of Radiology, Box 218, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, UK.

Publication Dates:

Publication Date:
17 Dec 2008

Licence:
Creative Commons Attribution


Article Categories

  • ABN (13)
  • ABNT (20)
  • Alzheimer's Disease (8)
  • Aquired Brain Injury (21)
  • Australia/NewZealand (34)
  • Clinical Review (171)
  • Communication aids (1)
  • COVID-19 (16)
  • Dementia (17)
  • Epilepsy (31)
  • Headache (18)
  • History (53)
  • Huntington's Disease (3)
  • Movement Disorders (20)
  • Multiple Sclerosis (24)
  • Myasthenia Gravis (7)
  • Neurological Literature (12)
  • Neurological Signs (9)
  • Neuroopthalmology (5)
  • Neuropsychiatry (7)
  • Neurosurgery (40)
  • Nutrition (5)
  • Paediatric neurology (15)
  • Pain (9)
  • Parkinson's Disease (42)
  • Personal Perspectives (16)
  • Regeneration (3)
  • Rehabilitation (56)
  • Sleep (18)
  • Special Feature (52)
  • Stroke (27)

Computed tomography (CT) of the head was first used in clinical practice at the Atkinson Morley’s Hospital, London in 1972. On the earliest equipment, images were low resolution and tediously slow to acquire involving several hours of acquisition and processing time. Now, high resolution images of the brain can be obtained in a few seconds. Speed is a great strength of modern CT making it ideal for ill and poorly co-operative patients. Rapid data acquisition is exploited in contrast enhanced angiography and perfusion techniques, although these will not be discussed in detail in this article. CT is still the best method available to detect bony abnormalities and acute blood products. For these reasons, CT remains at the forefront of neuroradiology despite the remarkable advances in other imaging technologies.

Basic physics

X-ray images are formed by interactions of X-ray photons with matter. As photons pass through objects, they interact primarily with electrons. The photon may be completely absorbed releasing an electron from an atom (photoelectric effect). More usually, the photon is not fully absorbed but part of its energy is used to move an electron into a higher energy orbital (Compton effect). The photon emerges from this interaction with reduced energy and is slightly deflected from its original course. These effects on photons generate image contrast because tissues attenuate photons to differing extents depending on their electron density. The electron density of tissue components is quantified using CT and thus reliably differentiated.

CT uses data from a bank of detectors which are irradiated by a tube rotated around the patient. In the first generations of CT equipment, data was acquired slice by slice. A significant advance came with the development of slip ring technology which allows continuous gantry rotation around the patient and thus data acquisition from a volume of tissue (so called helical or spiral CT). This increases the speed of imaging and provides the information required for 3D reconstructions with no gaps between slices. The latest technology has taken this idea a step further, using a large bank of detectors capable of acquiring up to 320 slices in a single gantry rotation lasting less than a second (so called multislice, multidetector or volume CT).

Processing the data from detectors is a complicated process requiring powerful computers. Images are constructed using algorithms which not only localise anatomical structures but minimise artefacts. There are different algorithms available which demonstrate bone, brain and soft tissues optimally.

Approach to neurological CT

1. Anatomical localisation of lesions

One of the most difficult and important steps in trying to work out the nature of a lesion is to decide whether a mass arises inside the brain parenchyma or outside, usually from the meningeal coverings. A lesion within the brain parenchyma is termed intra-axial and one outside is extra-axial. The shape of a mass and its effect on neighbouring structures (such as displacement of brain and bone remodelling) are helpful in making this distinction. Parenchymal lesions can be usefully divided into those involving grey or white matter. For example, many tumours arise in white matter, whereas ischaemia typically affects grey matter, causing loss of grey-white differentiation.


Figure 1: Generations of CT scanners. A. Initial CT equipment used linear motion of tube and detector followed by rotation of the gantry by a few degrees. This process had to be repeated up to 30 times, resulting in acquisition times of 30-60 mins per slice. B. Later generations of CT scanners avoided the need for linear motion by using a fan beam. This reduced acquisition times to less than 1 minute per slice. C. Spiral or helical CT allows continuous gantry rotation while the patient is moved through the scanner. This further increased acquisition speed. D. Multislice equipment uses banks of detectors to acquire multiple slices (typically 64) per rotation so that the whole brain can be imaged in a few seconds.

Figure 2: X-ray photons of suitable energy interact with
electrons, either releasing them from the atom (ionisation) or pushing them into a higher energy orbital. In the process, the photon may be completely absorbed, or reduced in energy. The interaction may also cause deflection of the photon (see Table 2).

a. Skull/scalp (Figure 3)

Lytic or sclerotic metastatic bone lesions may be seen on CT. Fractures are often better seen on plain films than CT.


Figure 3: Scalp/skull lesions.
A. Skull lesions from Langerhan’s cell histiocytosis. B and C. Skull fracture. Note the full extent of the fracture is often better
appreciated on plain film (arrowheads indicate fracture).

b. Dura mater (Figure 4)

Most normal dura mater (apart from the falx and tentorium) is not seen on CT as it is applied to the skull.


Figure 4: Dura mater. A. Images with and without contrast medium. Meningioma with a wide base on the convexity dura. B.
Subdural haematoma extending along the dural surface of the hemisphere. C. Post contrast CT image with a subdural
empyema indicated by arrowheads. Note compression of the subarachnoid spaces.

c. Arachnoid mater/subarachnoid space (Figure 5)

CSF spaces are easily compressed by space occupying lesions or by brain swelling. In hydrocephalus, the ventricles are typically large with effacement of cerebral sulci. In young people the sulci are normally small and this can be misinterpreted as brain swelling. Enlargement of the sulci usually indicates volume loss, either focal (eg related to an infarct) or diffuse (usually related to atrophy/neurodegeneration). Increased density in the sulci typically indicates subarachnoid haemorrhage.


Figure 5: Arachnoid mater/ subarachnoid space.
A. Prominent subarachnoid spaces due to atrophy. B. Subarachnoid haemorrhage. C. Arachnoid cyst.

d. Grey matter (Figure 6)

Infarcts typically involve grey matter but contusions and low grade tumours may be seen here.


Figure 6: Grey matter.
A. Established cortical infarct in the anterior cerebral artery territory.
B. Calcified low grade oligodendroglioma.

e. White matter (Figure 7)

This is a typical site for high grade gliomas. Metastases and abscesses are often seen near the grey-white junction because of the high blood flow here, and the size of the vessels in which tumour cells and bacteria can lodge. Oedema also involves white matter (Figure 11).


Figure 7: White matter.
A and B. High grade glioma with vasogenic oedema (A before and B after contrast medium).
See Figure 11 for description of patterns of oedema.

f. Vessels (Figure 8)

Focal increased density in a vessel may indicate recent thrombosis. Aneurysms are rarely identified on unenhanced CT but may be seen following contrast enhancement.


Figure 8: Vessels.
Dense middle cerebral artery following
recent occlusion (arrowhead).

g. Blindspots (Figure 9)

Extracranial soft tissues may show pathology which is incidental to the symptoms for which imaging was performed. The sella, skull base and orbits are frequent blind spots.


Figure 9: Blindspots.
A. The sella is enlarged by a pituitary adenoma (arrowheads). B. Orbital mass (arrowheads). C. Lymphoma involving nasopharynx and infratemporal
fossa (arrowheads).

2. Characterising lesions

a. Density (Figure 10)

The CT density of different tissue types can be predicted (Fig 10a-e). In practice, tumour types cannot be precisely differentiated from density alone, but certain tumours (meningioma, lymphoma, medulloblastoma) tend to be higher density than others (glioma). Detection of calcium and blood is often easier on CT than MRI.


Figure 10: Density of lesions.
A. Hounsfield Units (HU). Each tissue type has a specific electron density which can be quantified into attenuation coefficients or Hounsfield Units. B. Coil inserted in an intracranial aneurysm is of very high density and causes artefact (HU>1000) because of the attenuation of the x-ray beam. C. Calcification in a low grade glioma (HU=500). D. Recent haemorrhage in a
subdural collection (HU=200). E. Dermoid containing fat (HU=-200).

b. Outline/ patterns of oedema (Figure 11)

Many benign tumours have well defined margins whereas aggressive tumours and inflammatory processes tend to be ill-defined. This does not apply universally and some rapidly growing tumours may appear well-defined. Vasogenic oedema is caused by disruption of the blood brain barrier around inflammatory, neoplastic or ischaemic lesions. This is usually confined to white matter. Cytotoxic oedema is caused by ischaemia and involves grey and white matter.


Figure 11: Outline/ patterns of oedema.
A and B. Pre- and post-contrast imaging. Meningioma showing a well defined margin. C and D. Pre- and post-contrast imaging. Glioma showing ill defined margins. E. Vasogenic oedema involving white matter only, in a case of olfactory groove meningioma (tumour not shown).

Figure 11
F. Cytotoxic oedema involving grey and white matter in diffuse cortical necrosis following cardiac arrest. G. Normal brain for comparison

c. Contrast enhancement (Figure 12)

Contrast enhancement is caused by a combination of increased vascularity and disruption of the blood brain barrier. Patterns of enhancement clarifies the extent of abnormality and can help differentiate disease processes.


Figure 12: Patterns of contrast enhancement.
A. Image before and after IV contrast medium. Homogeneous enhancement in a meningioma. B. Image before and after iv contrast medium. Heterogeneous enhancement in a glioma.

| Sign up to the ACNR email newsletter here |

d. Mass effect (Figure 13)

Recognising the consequences of mass effect is important as shift between intracranial compartments can result in rapid clinical deterioration because of pressure on vital structures.


Figure 13: Mass effect.
Diffusely swollen brain with effacement of perimesencephalic cisterns indicating trans-tentorial herniation (arrowheads).

3. Recognising artefacts (Figure 14)

The appearance of artefacts is learned through experience but a few examples are provided in Figure 14.


Figure 14: Artefacts (see Table 3).
A. Beam hardening causing apparent low density in the brainstem (arrowheads). B. Back projection or star artefact around a dense metal coil. C. Motion artefact on multislice CT can result in an unusual appearance with distortion of only part of the image.

Conclusion

Neurological CT continues to develop rapidly with new technology becoming available almost every year. CT is not only the first line neurological imaging investigation, but also provides excellent diagnostic information which is complementary to other techniques such as MRI. More advanced applications of CT such as angiographic imaging and quantification of perfusion have not been covered in this article, but are becoming more widely used in clinical practice.

References

1. Smirniotopoulos JG, Murphy FM, Rushing EJ et al. Patterns of contrast enhancement in the brain and meninges. Radiographics 2007;27: 525-51.

2. Osborn AG, Blaser S, Salzman K et al. Diagnostic Imaging: Brain. Amirsys 2004.

Related

  • Published by Whitehouse Publishing
  • The Lynch, Mere, Wiltshire BA12 6DQ, United Kingdom
  • info@acnr.co.uk
  • +44 1747 860168

FOLLOW US

  • Facebook
  • Instagram
  • X
  • Linkedin

RSS FEEDS

  • ACNR RSS
  • All
  • Articles
  • Events

ACNR SIGNUPS

Join our email list to be notified when there is new content or upcoming events.

© 2026 ACNR. Published by Whitehouse Publishing. Read our Privacy and Cookie Policy. Website by Sugar Web.

SIGN UP FOR OUR EMAILING LIST

Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified.

For UK-based specialists, sign up for our journal mailing list.

WARNING

URL here

You are now leaving the ACNR website, please click the "Continue" button below. If you do not wish to leave, please close this pop-up.

Continue